Migraine Stocks List

Migraine Stocks Recent News

Date Stock Title
Jul 3 ASRT H.C. Wainwright starts Assertio at buy, calls stock underrated, overlooked
Jul 3 ABBV AbbVie Q2 IPR&D expenses to lower EPS by $0.52
Jul 3 ABBV Company News for Jul 3, 2024
Jul 3 ABBV AbbVie: A Hold Again (Rating Downgrade)
Jul 2 ABBV With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backing
Jul 2 ABBV AbbVie to Host Second-Quarter 2024 Earnings Conference Call
Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
Jul 1 AMRX Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)
Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
Jul 1 AMRX Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar
Jul 1 ABBV 3 Magnificent Stocks Retirees Can Buy and Hold Forever
Jul 1 ABBV 10 clinical trials to watch in the second half of 2024
Jun 29 ABBV How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
Jun 28 ABBV How Medicare drug price negotiations could hit pharma stocks
Jun 28 ABBV Coherus offloads Humira biosimilar Yusimry for $40m
Jun 28 ABBV AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
Jun 28 ABBV AbbVie, Genmab blood cancer therapy endorsed in EU
Jun 28 ABBV Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Migraine

A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity. Up to one-third of people have an aura: typically a short period of visual disturbance that signals that the headache will soon occur. Occasionally, an aura can occur with little or no headache following it.Migraines are believed to be due to a mixture of environmental and genetic factors. About two-thirds of cases run in families. Changing hormone levels may also play a role, as migraines affect slightly more boys than girls before puberty and two to three times more women than men. The risk of migraines usually decreases during pregnancy. The underlying mechanisms are not fully known. They are, however, believed to involve the nerves and blood vessels of the brain.Initial recommended treatment is with simple pain medication such as ibuprofen and paracetamol (acetaminophen) for the headache, medication for the nausea, and the avoidance of triggers. Specific medications such as triptans or ergotamines may be used in those for whom simple pain medications are not effective. Caffeine may be added to the above. A number of medications are useful to prevent attacks including metoprolol, valproate, and topiramate.Globally, approximately 15% of people are affected by migraines. It most often starts at puberty and is worst during middle age. In some women they become less common following menopause. As of 2016 it is one of the most common causes of disability. An early description consistent with migraines is contained in the Ebers papyrus, written around 1500 BCE in ancient Egypt. The word "migraine" is from the Greek ἡμικρανία (hemikrania), "pain on one side of the head", from ἡμι- (hemi-), "half", and κρανίον (kranion), "skull".

Browse All Tags